Upstream Bio, Inc.
UPB
$5.96
-$0.23-3.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.19% | 4.40% | -25.81% | 15.56% | -46.56% |
| Total Depreciation and Amortization | 2.04% | -14.04% | 23.91% | 9.52% | -2.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.56% | 0.50% | 55.79% | 47.60% | 69.25% |
| Change in Net Operating Assets | 96.12% | -246.56% | -12.75% | 933.71% | 92.89% |
| Cash from Operations | 25.56% | -56.22% | -37.73% | 43.32% | 4.68% |
| Capital Expenditure | -- | -- | 15.63% | -36.17% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.83% | -28.13% | 22.27% | 276.37% | 106.01% |
| Cash from Investing | -62.83% | -28.06% | 22.32% | 277.25% | 105.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 323.58% | -45.78% | 45.13% | 24.18% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 323.58% | -45.78% | 45.13% | 24.18% | 1,900.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -256.96% | -116.50% | 10.14% | 203.30% | 89.84% |